nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—CYP3A4—Everolimus—kidney cancer	0.121	0.293	CbGbCtD
Sibutramine—CYP3A4—Temsirolimus—kidney cancer	0.0819	0.198	CbGbCtD
Sibutramine—CYP3A4—Pazopanib—kidney cancer	0.043	0.104	CbGbCtD
Sibutramine—CYP3A4—Erlotinib—kidney cancer	0.0307	0.0741	CbGbCtD
Sibutramine—CYP3A4—Paclitaxel—kidney cancer	0.0281	0.0678	CbGbCtD
Sibutramine—CYP3A4—Sorafenib—kidney cancer	0.025	0.0603	CbGbCtD
Sibutramine—CYP3A4—Vinblastine—kidney cancer	0.0247	0.0595	CbGbCtD
Sibutramine—CYP3A4—Vincristine—kidney cancer	0.0242	0.0585	CbGbCtD
Sibutramine—CYP3A4—Sunitinib—kidney cancer	0.0202	0.0488	CbGbCtD
Sibutramine—CYP3A4—Doxorubicin—kidney cancer	0.0152	0.0366	CbGbCtD
Sibutramine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—kidney cancer	0.000913	0.0703	CbGpPWpGaD
Sibutramine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—kidney cancer	0.000795	0.0612	CbGpPWpGaD
Sibutramine—SLC6A3—Dopaminergic Neurogenesis—ALDH1A1—kidney cancer	0.00054	0.0416	CbGpPWpGaD
Sibutramine—SLC6A3—Parkinsons Disease Pathway—LRRK2—kidney cancer	0.000468	0.0361	CbGpPWpGaD
Sibutramine—CYP3A4—Aflatoxin activation and detoxification—ACY1—kidney cancer	0.000435	0.0335	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—ACHE—kidney cancer	0.000395	0.0304	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—ACHE—kidney cancer	0.00034	0.0262	CbGpPWpGaD
Sibutramine—SLC6A3—Parkinsons Disease Pathway—CASP2—kidney cancer	0.000339	0.0261	CbGpPWpGaD
Sibutramine—SLC6A3—Parkinsons Disease Pathway—APAF1—kidney cancer	0.000318	0.0245	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—ACHE—kidney cancer	0.000301	0.0232	CbGpPWpGaD
Sibutramine—CYP3A4—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000273	0.021	CbGpPWpGaD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000228	0.0176	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—TSC2—kidney cancer	0.000212	0.0163	CbGpPWpGaD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000202	0.0156	CbGpPWpGaD
Sibutramine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—kidney cancer	0.000198	0.0153	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—SLC5A3—kidney cancer	0.000192	0.0147	CbGpPWpGaD
Sibutramine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000183	0.0141	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—TSC2—kidney cancer	0.000182	0.014	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—KEAP1—kidney cancer	0.000167	0.0129	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—SLC5A3—kidney cancer	0.000165	0.0127	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—TSC2—kidney cancer	0.000161	0.0124	CbGpPWpGaD
Sibutramine—Gastrointestinal pain—Vincristine—kidney cancer	0.000157	0.000274	CcSEcCtD
Sibutramine—Cardiac arrest—Doxorubicin—kidney cancer	0.000156	0.000272	CcSEcCtD
Sibutramine—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	0.000156	0.012	CbGpPWpGaD
Sibutramine—Dizziness—Sorafenib—kidney cancer	0.000156	0.000272	CcSEcCtD
Sibutramine—Pain—Gemcitabine—kidney cancer	0.000155	0.000271	CcSEcCtD
Sibutramine—Constipation—Gemcitabine—kidney cancer	0.000155	0.000271	CcSEcCtD
Sibutramine—Nausea—Erlotinib—kidney cancer	0.000155	0.000271	CcSEcCtD
Sibutramine—Alopecia—Capecitabine—kidney cancer	0.000155	0.000271	CcSEcCtD
Sibutramine—Dry mouth—Paclitaxel—kidney cancer	0.000155	0.000271	CcSEcCtD
Sibutramine—Mood swings—Doxorubicin—kidney cancer	0.000155	0.000271	CcSEcCtD
Sibutramine—Diarrhoea—Sunitinib—kidney cancer	0.000155	0.000271	CcSEcCtD
Sibutramine—Ataxia—Doxorubicin—kidney cancer	0.000154	0.000269	CcSEcCtD
Sibutramine—Asthenia—Dactinomycin—kidney cancer	0.000154	0.000269	CcSEcCtD
Sibutramine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	0.000154	0.0118	CbGpPWpGaD
Sibutramine—Confusional state—Paclitaxel—kidney cancer	0.000153	0.000268	CcSEcCtD
Sibutramine—Blood creatinine increased—Doxorubicin—kidney cancer	0.000153	0.000268	CcSEcCtD
Sibutramine—Malnutrition—Capecitabine—kidney cancer	0.000153	0.000267	CcSEcCtD
Sibutramine—Dehydration—Doxorubicin—kidney cancer	0.000152	0.000266	CcSEcCtD
Sibutramine—Oedema—Paclitaxel—kidney cancer	0.000152	0.000266	CcSEcCtD
Sibutramine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000152	0.000266	CcSEcCtD
Sibutramine—Abdominal pain—Vincristine—kidney cancer	0.000151	0.000264	CcSEcCtD
Sibutramine—Body temperature increased—Vincristine—kidney cancer	0.000151	0.000264	CcSEcCtD
Sibutramine—Liver function test abnormal—Doxorubicin—kidney cancer	0.000151	0.000264	CcSEcCtD
Sibutramine—Infection—Paclitaxel—kidney cancer	0.000151	0.000264	CcSEcCtD
Sibutramine—Flatulence—Capecitabine—kidney cancer	0.000151	0.000263	CcSEcCtD
Sibutramine—Dry skin—Doxorubicin—kidney cancer	0.00015	0.000262	CcSEcCtD
Sibutramine—Dysgeusia—Capecitabine—kidney cancer	0.00015	0.000262	CcSEcCtD
Sibutramine—Dizziness—Sunitinib—kidney cancer	0.00015	0.000262	CcSEcCtD
Sibutramine—Feeling abnormal—Gemcitabine—kidney cancer	0.00015	0.000261	CcSEcCtD
Sibutramine—Shock—Paclitaxel—kidney cancer	0.00015	0.000261	CcSEcCtD
Sibutramine—Vomiting—Sorafenib—kidney cancer	0.00015	0.000261	CcSEcCtD
Sibutramine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00015	0.000261	CcSEcCtD
Sibutramine—Hypokalaemia—Doxorubicin—kidney cancer	0.000149	0.00026	CcSEcCtD
Sibutramine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000149	0.00026	CcSEcCtD
Sibutramine—Tachycardia—Paclitaxel—kidney cancer	0.000148	0.000259	CcSEcCtD
Sibutramine—Rash—Sorafenib—kidney cancer	0.000148	0.000259	CcSEcCtD
Sibutramine—Dermatitis—Sorafenib—kidney cancer	0.000148	0.000259	CcSEcCtD
Sibutramine—Back pain—Capecitabine—kidney cancer	0.000148	0.000258	CcSEcCtD
Sibutramine—Skin disorder—Paclitaxel—kidney cancer	0.000148	0.000258	CcSEcCtD
Sibutramine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000147	0.000257	CcSEcCtD
Sibutramine—Headache—Sorafenib—kidney cancer	0.000147	0.000257	CcSEcCtD
Sibutramine—Muscle spasms—Capecitabine—kidney cancer	0.000147	0.000257	CcSEcCtD
Sibutramine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000147	0.000257	CcSEcCtD
Sibutramine—Diarrhoea—Dactinomycin—kidney cancer	0.000147	0.000256	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—SLC5A3—kidney cancer	0.000146	0.0112	CbGpPWpGaD
Sibutramine—Anorexia—Paclitaxel—kidney cancer	0.000145	0.000253	CcSEcCtD
Sibutramine—Gastritis—Doxorubicin—kidney cancer	0.000145	0.000253	CcSEcCtD
Sibutramine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000144	0.000252	CcSEcCtD
Sibutramine—Muscular weakness—Doxorubicin—kidney cancer	0.000144	0.000252	CcSEcCtD
Sibutramine—Vision blurred—Capecitabine—kidney cancer	0.000144	0.000252	CcSEcCtD
Sibutramine—Vomiting—Sunitinib—kidney cancer	0.000144	0.000251	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—KEAP1—kidney cancer	0.000144	0.0111	CbGpPWpGaD
Sibutramine—Body temperature increased—Gemcitabine—kidney cancer	0.000144	0.000251	CcSEcCtD
Sibutramine—Tremor—Capecitabine—kidney cancer	0.000143	0.00025	CcSEcCtD
Sibutramine—Rash—Sunitinib—kidney cancer	0.000143	0.000249	CcSEcCtD
Sibutramine—Dermatitis—Sunitinib—kidney cancer	0.000143	0.000249	CcSEcCtD
Sibutramine—Abdominal distension—Doxorubicin—kidney cancer	0.000142	0.000249	CcSEcCtD
Sibutramine—Hypotension—Paclitaxel—kidney cancer	0.000142	0.000248	CcSEcCtD
Sibutramine—Ill-defined disorder—Capecitabine—kidney cancer	0.000142	0.000248	CcSEcCtD
Sibutramine—Headache—Sunitinib—kidney cancer	0.000142	0.000248	CcSEcCtD
Sibutramine—Dysphagia—Doxorubicin—kidney cancer	0.000142	0.000247	CcSEcCtD
Sibutramine—Influenza—Doxorubicin—kidney cancer	0.000142	0.000247	CcSEcCtD
Sibutramine—Asthma—Doxorubicin—kidney cancer	0.000142	0.000247	CcSEcCtD
Sibutramine—Anaemia—Capecitabine—kidney cancer	0.000141	0.000247	CcSEcCtD
Sibutramine—Hypersensitivity—Vincristine—kidney cancer	0.000141	0.000246	CcSEcCtD
Sibutramine—Eosinophilia—Doxorubicin—kidney cancer	0.00014	0.000245	CcSEcCtD
Sibutramine—Nausea—Sorafenib—kidney cancer	0.00014	0.000244	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000139	0.000242	CcSEcCtD
Sibutramine—Malaise—Capecitabine—kidney cancer	0.000138	0.000241	CcSEcCtD
Sibutramine—Angina pectoris—Doxorubicin—kidney cancer	0.000138	0.000241	CcSEcCtD
Sibutramine—Insomnia—Paclitaxel—kidney cancer	0.000138	0.00024	CcSEcCtD
Sibutramine—Vertigo—Capecitabine—kidney cancer	0.000137	0.00024	CcSEcCtD
Sibutramine—Asthenia—Vincristine—kidney cancer	0.000137	0.00024	CcSEcCtD
Sibutramine—Syncope—Capecitabine—kidney cancer	0.000137	0.00024	CcSEcCtD
Sibutramine—Leukopenia—Capecitabine—kidney cancer	0.000137	0.000239	CcSEcCtD
Sibutramine—Paraesthesia—Paclitaxel—kidney cancer	0.000137	0.000239	CcSEcCtD
Sibutramine—Vomiting—Dactinomycin—kidney cancer	0.000136	0.000238	CcSEcCtD
Sibutramine—Bronchitis—Doxorubicin—kidney cancer	0.000136	0.000238	CcSEcCtD
Sibutramine—Dyspnoea—Paclitaxel—kidney cancer	0.000136	0.000237	CcSEcCtD
Sibutramine—Somnolence—Paclitaxel—kidney cancer	0.000135	0.000236	CcSEcCtD
Sibutramine—Palpitations—Capecitabine—kidney cancer	0.000135	0.000236	CcSEcCtD
Sibutramine—Rash—Dactinomycin—kidney cancer	0.000135	0.000236	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.000135	0.0104	CbGpPWpGaD
Sibutramine—Nausea—Sunitinib—kidney cancer	0.000135	0.000235	CcSEcCtD
Sibutramine—Loss of consciousness—Capecitabine—kidney cancer	0.000134	0.000235	CcSEcCtD
Sibutramine—Dyspepsia—Paclitaxel—kidney cancer	0.000134	0.000234	CcSEcCtD
Sibutramine—Cough—Capecitabine—kidney cancer	0.000133	0.000233	CcSEcCtD
Sibutramine—Dysuria—Doxorubicin—kidney cancer	0.000132	0.000231	CcSEcCtD
Sibutramine—Decreased appetite—Paclitaxel—kidney cancer	0.000132	0.000231	CcSEcCtD
Sibutramine—Hypertension—Capecitabine—kidney cancer	0.000132	0.000231	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000131	0.000229	CcSEcCtD
Sibutramine—Diarrhoea—Vincristine—kidney cancer	0.000131	0.000229	CcSEcCtD
Sibutramine—Pollakiuria—Doxorubicin—kidney cancer	0.000131	0.000228	CcSEcCtD
Sibutramine—Asthenia—Gemcitabine—kidney cancer	0.00013	0.000228	CcSEcCtD
Sibutramine—Chest pain—Capecitabine—kidney cancer	0.00013	0.000227	CcSEcCtD
Sibutramine—Arthralgia—Capecitabine—kidney cancer	0.00013	0.000227	CcSEcCtD
Sibutramine—Myalgia—Capecitabine—kidney cancer	0.00013	0.000227	CcSEcCtD
Sibutramine—Constipation—Paclitaxel—kidney cancer	0.00013	0.000227	CcSEcCtD
Sibutramine—Pain—Paclitaxel—kidney cancer	0.00013	0.000227	CcSEcCtD
Sibutramine—Anxiety—Capecitabine—kidney cancer	0.00013	0.000227	CcSEcCtD
Sibutramine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000129	0.000226	CcSEcCtD
Sibutramine—Weight increased—Doxorubicin—kidney cancer	0.000129	0.000225	CcSEcCtD
Sibutramine—Discomfort—Capecitabine—kidney cancer	0.000129	0.000225	CcSEcCtD
Sibutramine—Pruritus—Gemcitabine—kidney cancer	0.000129	0.000225	CcSEcCtD
Sibutramine—Hyperglycaemia—Doxorubicin—kidney cancer	0.000128	0.000223	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—KEAP1—kidney cancer	0.000128	0.00982	CbGpPWpGaD
Sibutramine—Dry mouth—Capecitabine—kidney cancer	0.000127	0.000222	CcSEcCtD
Sibutramine—Nausea—Dactinomycin—kidney cancer	0.000127	0.000222	CcSEcCtD
Sibutramine—Pneumonia—Doxorubicin—kidney cancer	0.000127	0.000222	CcSEcCtD
Sibutramine—Dizziness—Vincristine—kidney cancer	0.000127	0.000221	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—HNF1B—kidney cancer	0.000126	0.00971	CbGpPWpGaD
Sibutramine—Confusional state—Capecitabine—kidney cancer	0.000126	0.00022	CcSEcCtD
Sibutramine—Feeling abnormal—Paclitaxel—kidney cancer	0.000125	0.000219	CcSEcCtD
Sibutramine—Oedema—Capecitabine—kidney cancer	0.000125	0.000218	CcSEcCtD
Sibutramine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000124	0.000217	CcSEcCtD
Sibutramine—Diarrhoea—Gemcitabine—kidney cancer	0.000124	0.000217	CcSEcCtD
Sibutramine—Renal failure—Doxorubicin—kidney cancer	0.000124	0.000217	CcSEcCtD
Sibutramine—Infection—Capecitabine—kidney cancer	0.000124	0.000217	CcSEcCtD
Sibutramine—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000124	0.000216	CcSEcCtD
Sibutramine—Stomatitis—Doxorubicin—kidney cancer	0.000123	0.000215	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—KCNMA1—kidney cancer	0.000123	0.00946	CbGpPWpGaD
Sibutramine—Shock—Capecitabine—kidney cancer	0.000123	0.000215	CcSEcCtD
Sibutramine—Conjunctivitis—Doxorubicin—kidney cancer	0.000123	0.000214	CcSEcCtD
Sibutramine—Urinary tract infection—Doxorubicin—kidney cancer	0.000123	0.000214	CcSEcCtD
Sibutramine—Thrombocytopenia—Capecitabine—kidney cancer	0.000122	0.000213	CcSEcCtD
Sibutramine—Tachycardia—Capecitabine—kidney cancer	0.000122	0.000213	CcSEcCtD
Sibutramine—Vomiting—Vincristine—kidney cancer	0.000122	0.000213	CcSEcCtD
Sibutramine—Skin disorder—Capecitabine—kidney cancer	0.000121	0.000212	CcSEcCtD
Sibutramine—Sweating—Doxorubicin—kidney cancer	0.000121	0.000211	CcSEcCtD
Sibutramine—Urticaria—Paclitaxel—kidney cancer	0.000121	0.000211	CcSEcCtD
Sibutramine—Rash—Vincristine—kidney cancer	0.000121	0.000211	CcSEcCtD
Sibutramine—Hyperhidrosis—Capecitabine—kidney cancer	0.000121	0.000211	CcSEcCtD
Sibutramine—Dermatitis—Vincristine—kidney cancer	0.000121	0.000211	CcSEcCtD
Sibutramine—Haematuria—Doxorubicin—kidney cancer	0.00012	0.00021	CcSEcCtD
Sibutramine—Body temperature increased—Paclitaxel—kidney cancer	0.00012	0.00021	CcSEcCtD
Sibutramine—Abdominal pain—Paclitaxel—kidney cancer	0.00012	0.00021	CcSEcCtD
Sibutramine—Headache—Vincristine—kidney cancer	0.00012	0.00021	CcSEcCtD
Sibutramine—Epistaxis—Doxorubicin—kidney cancer	0.000119	0.000208	CcSEcCtD
Sibutramine—Anorexia—Capecitabine—kidney cancer	0.000119	0.000208	CcSEcCtD
Sibutramine—Sinusitis—Doxorubicin—kidney cancer	0.000118	0.000207	CcSEcCtD
Sibutramine—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000117	0.00904	CbGpPWpGaD
Sibutramine—Hypotension—Capecitabine—kidney cancer	0.000117	0.000204	CcSEcCtD
Sibutramine—Vomiting—Gemcitabine—kidney cancer	0.000116	0.000202	CcSEcCtD
Sibutramine—Bradycardia—Doxorubicin—kidney cancer	0.000115	0.000201	CcSEcCtD
Sibutramine—Rash—Gemcitabine—kidney cancer	0.000115	0.0002	CcSEcCtD
Sibutramine—Dermatitis—Gemcitabine—kidney cancer	0.000114	0.0002	CcSEcCtD
Sibutramine—Haemoglobin—Doxorubicin—kidney cancer	0.000114	0.000199	CcSEcCtD
Sibutramine—Headache—Gemcitabine—kidney cancer	0.000114	0.000199	CcSEcCtD
Sibutramine—Nausea—Vincristine—kidney cancer	0.000114	0.000199	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000114	0.000199	CcSEcCtD
Sibutramine—Rhinitis—Doxorubicin—kidney cancer	0.000114	0.000198	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL13—kidney cancer	0.000113	0.00873	CbGpPWpGaD
Sibutramine—Haemorrhage—Doxorubicin—kidney cancer	0.000113	0.000198	CcSEcCtD
Sibutramine—Insomnia—Capecitabine—kidney cancer	0.000113	0.000197	CcSEcCtD
Sibutramine—Hypoaesthesia—Doxorubicin—kidney cancer	0.000113	0.000197	CcSEcCtD
Sibutramine—Pharyngitis—Doxorubicin—kidney cancer	0.000112	0.000196	CcSEcCtD
Sibutramine—Paraesthesia—Capecitabine—kidney cancer	0.000112	0.000196	CcSEcCtD
Sibutramine—Hypersensitivity—Paclitaxel—kidney cancer	0.000112	0.000196	CcSEcCtD
Sibutramine—Oedema peripheral—Doxorubicin—kidney cancer	0.000112	0.000195	CcSEcCtD
Sibutramine—Dyspnoea—Capecitabine—kidney cancer	0.000111	0.000194	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—JUND—kidney cancer	0.00011	0.00849	CbGpPWpGaD
Sibutramine—Dyspepsia—Capecitabine—kidney cancer	0.00011	0.000192	CcSEcCtD
Sibutramine—Visual impairment—Doxorubicin—kidney cancer	0.000109	0.000191	CcSEcCtD
Sibutramine—Asthenia—Paclitaxel—kidney cancer	0.000109	0.000191	CcSEcCtD
Sibutramine—Decreased appetite—Capecitabine—kidney cancer	0.000109	0.00019	CcSEcCtD
Sibutramine—Nausea—Gemcitabine—kidney cancer	0.000108	0.000188	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000108	0.000188	CcSEcCtD
Sibutramine—Pruritus—Paclitaxel—kidney cancer	0.000108	0.000188	CcSEcCtD
Sibutramine—Constipation—Capecitabine—kidney cancer	0.000107	0.000186	CcSEcCtD
Sibutramine—Pain—Capecitabine—kidney cancer	0.000107	0.000186	CcSEcCtD
Sibutramine—Eye disorder—Doxorubicin—kidney cancer	0.000106	0.000185	CcSEcCtD
Sibutramine—Tinnitus—Doxorubicin—kidney cancer	0.000106	0.000184	CcSEcCtD
Sibutramine—Diarrhoea—Paclitaxel—kidney cancer	0.000104	0.000182	CcSEcCtD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000104	0.00799	CbGpPWpGaD
Sibutramine—Feeling abnormal—Capecitabine—kidney cancer	0.000103	0.00018	CcSEcCtD
Sibutramine—Angiopathy—Doxorubicin—kidney cancer	0.000103	0.000179	CcSEcCtD
Sibutramine—Immune system disorder—Doxorubicin—kidney cancer	0.000102	0.000179	CcSEcCtD
Sibutramine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000102	0.000178	CcSEcCtD
Sibutramine—Chills—Doxorubicin—kidney cancer	0.000102	0.000177	CcSEcCtD
Sibutramine—Arrhythmia—Doxorubicin—kidney cancer	0.000101	0.000177	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—SLC5A5—kidney cancer	0.000101	0.00778	CbGpPWpGaD
Sibutramine—Dizziness—Paclitaxel—kidney cancer	0.000101	0.000176	CcSEcCtD
Sibutramine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.0001	0.00773	CbGpPWpGaD
Sibutramine—Alopecia—Doxorubicin—kidney cancer	0.0001	0.000175	CcSEcCtD
Sibutramine—Urticaria—Capecitabine—kidney cancer	9.92e-05	0.000173	CcSEcCtD
Sibutramine—Abdominal pain—Capecitabine—kidney cancer	9.87e-05	0.000172	CcSEcCtD
Sibutramine—Body temperature increased—Capecitabine—kidney cancer	9.87e-05	0.000172	CcSEcCtD
Sibutramine—Malnutrition—Doxorubicin—kidney cancer	9.86e-05	0.000172	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—SLC2A1—kidney cancer	9.76e-05	0.00751	CbGpPWpGaD
Sibutramine—Flatulence—Doxorubicin—kidney cancer	9.72e-05	0.00017	CcSEcCtD
Sibutramine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	9.7e-05	0.00747	CbGpPWpGaD
Sibutramine—Tension—Doxorubicin—kidney cancer	9.68e-05	0.000169	CcSEcCtD
Sibutramine—Vomiting—Paclitaxel—kidney cancer	9.67e-05	0.000169	CcSEcCtD
Sibutramine—Dysgeusia—Doxorubicin—kidney cancer	9.66e-05	0.000169	CcSEcCtD
Sibutramine—Rash—Paclitaxel—kidney cancer	9.59e-05	0.000168	CcSEcCtD
Sibutramine—Dermatitis—Paclitaxel—kidney cancer	9.58e-05	0.000167	CcSEcCtD
Sibutramine—Nervousness—Doxorubicin—kidney cancer	9.58e-05	0.000167	CcSEcCtD
Sibutramine—Back pain—Doxorubicin—kidney cancer	9.54e-05	0.000167	CcSEcCtD
Sibutramine—Headache—Paclitaxel—kidney cancer	9.53e-05	0.000166	CcSEcCtD
Sibutramine—Muscle spasms—Doxorubicin—kidney cancer	9.48e-05	0.000166	CcSEcCtD
Sibutramine—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	9.31e-05	0.00717	CbGpPWpGaD
Sibutramine—Vision blurred—Doxorubicin—kidney cancer	9.29e-05	0.000162	CcSEcCtD
Sibutramine—Hypersensitivity—Capecitabine—kidney cancer	9.2e-05	0.000161	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	9.2e-05	0.00708	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—RYR1—kidney cancer	9.18e-05	0.00707	CbGpPWpGaD
Sibutramine—Ill-defined disorder—Doxorubicin—kidney cancer	9.15e-05	0.00016	CcSEcCtD
Sibutramine—Anaemia—Doxorubicin—kidney cancer	9.11e-05	0.000159	CcSEcCtD
Sibutramine—Agitation—Doxorubicin—kidney cancer	9.06e-05	0.000158	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—EGR1—kidney cancer	9.06e-05	0.00697	CbGpPWpGaD
Sibutramine—Nausea—Paclitaxel—kidney cancer	9.04e-05	0.000158	CcSEcCtD
Sibutramine—Asthenia—Capecitabine—kidney cancer	8.96e-05	0.000156	CcSEcCtD
Sibutramine—Malaise—Doxorubicin—kidney cancer	8.89e-05	0.000155	CcSEcCtD
Sibutramine—Vertigo—Doxorubicin—kidney cancer	8.86e-05	0.000155	CcSEcCtD
Sibutramine—Syncope—Doxorubicin—kidney cancer	8.84e-05	0.000154	CcSEcCtD
Sibutramine—Pruritus—Capecitabine—kidney cancer	8.83e-05	0.000154	CcSEcCtD
Sibutramine—Leukopenia—Doxorubicin—kidney cancer	8.83e-05	0.000154	CcSEcCtD
Sibutramine—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	8.83e-05	0.00679	CbGpPWpGaD
Sibutramine—Palpitations—Doxorubicin—kidney cancer	8.71e-05	0.000152	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—SLC5A5—kidney cancer	8.69e-05	0.00669	CbGpPWpGaD
Sibutramine—Loss of consciousness—Doxorubicin—kidney cancer	8.67e-05	0.000151	CcSEcCtD
Sibutramine—Cough—Doxorubicin—kidney cancer	8.61e-05	0.00015	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—EGR1—kidney cancer	8.59e-05	0.00661	CbGpPWpGaD
Sibutramine—Convulsion—Doxorubicin—kidney cancer	8.54e-05	0.000149	CcSEcCtD
Sibutramine—Diarrhoea—Capecitabine—kidney cancer	8.54e-05	0.000149	CcSEcCtD
Sibutramine—Hypertension—Doxorubicin—kidney cancer	8.51e-05	0.000149	CcSEcCtD
Sibutramine—CYP3A4—Irinotecan Pathway—APC—kidney cancer	8.45e-05	0.00651	CbGpPWpGaD
Sibutramine—Arthralgia—Doxorubicin—kidney cancer	8.4e-05	0.000147	CcSEcCtD
Sibutramine—Myalgia—Doxorubicin—kidney cancer	8.4e-05	0.000147	CcSEcCtD
Sibutramine—Chest pain—Doxorubicin—kidney cancer	8.4e-05	0.000147	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—SLC2A1—kidney cancer	8.39e-05	0.00646	CbGpPWpGaD
Sibutramine—Anxiety—Doxorubicin—kidney cancer	8.37e-05	0.000146	CcSEcCtD
Sibutramine—Discomfort—Doxorubicin—kidney cancer	8.29e-05	0.000145	CcSEcCtD
Sibutramine—Dizziness—Capecitabine—kidney cancer	8.26e-05	0.000144	CcSEcCtD
Sibutramine—Dry mouth—Doxorubicin—kidney cancer	8.21e-05	0.000143	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—GSTP1—kidney cancer	8.14e-05	0.00626	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—RYR1—kidney cancer	8.14e-05	0.00626	CbGpPWpGaD
Sibutramine—Confusional state—Doxorubicin—kidney cancer	8.12e-05	0.000142	CcSEcCtD
Sibutramine—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	8.11e-05	0.00625	CbGpPWpGaD
Sibutramine—Oedema—Doxorubicin—kidney cancer	8.05e-05	0.000141	CcSEcCtD
Sibutramine—Anaphylactic shock—Doxorubicin—kidney cancer	8.05e-05	0.000141	CcSEcCtD
Sibutramine—Infection—Doxorubicin—kidney cancer	8e-05	0.00014	CcSEcCtD
Sibutramine—Vomiting—Capecitabine—kidney cancer	7.94e-05	0.000139	CcSEcCtD
Sibutramine—Shock—Doxorubicin—kidney cancer	7.92e-05	0.000138	CcSEcCtD
Sibutramine—Thrombocytopenia—Doxorubicin—kidney cancer	7.88e-05	0.000138	CcSEcCtD
Sibutramine—Rash—Capecitabine—kidney cancer	7.87e-05	0.000137	CcSEcCtD
Sibutramine—Dermatitis—Capecitabine—kidney cancer	7.87e-05	0.000137	CcSEcCtD
Sibutramine—Tachycardia—Doxorubicin—kidney cancer	7.85e-05	0.000137	CcSEcCtD
Sibutramine—Headache—Capecitabine—kidney cancer	7.82e-05	0.000137	CcSEcCtD
Sibutramine—Skin disorder—Doxorubicin—kidney cancer	7.82e-05	0.000137	CcSEcCtD
Sibutramine—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	7.8e-05	0.00601	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—EGR1—kidney cancer	7.79e-05	0.006	CbGpPWpGaD
Sibutramine—Hyperhidrosis—Doxorubicin—kidney cancer	7.78e-05	0.000136	CcSEcCtD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	7.7e-05	0.00593	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—SLC5A5—kidney cancer	7.7e-05	0.00592	CbGpPWpGaD
Sibutramine—Anorexia—Doxorubicin—kidney cancer	7.67e-05	0.000134	CcSEcCtD
Sibutramine—Hypotension—Doxorubicin—kidney cancer	7.52e-05	0.000131	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—GSTM1—kidney cancer	7.48e-05	0.00576	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—ACY1—kidney cancer	7.46e-05	0.00574	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—SLC2A1—kidney cancer	7.43e-05	0.00572	CbGpPWpGaD
Sibutramine—Nausea—Capecitabine—kidney cancer	7.42e-05	0.00013	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.33e-05	0.000128	CcSEcCtD
Sibutramine—Insomnia—Doxorubicin—kidney cancer	7.28e-05	0.000127	CcSEcCtD
Sibutramine—Paraesthesia—Doxorubicin—kidney cancer	7.23e-05	0.000126	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—KCNMA1—kidney cancer	7.2e-05	0.00554	CbGpPWpGaD
Sibutramine—Dyspnoea—Doxorubicin—kidney cancer	7.18e-05	0.000125	CcSEcCtD
Sibutramine—Somnolence—Doxorubicin—kidney cancer	7.15e-05	0.000125	CcSEcCtD
Sibutramine—Dyspepsia—Doxorubicin—kidney cancer	7.08e-05	0.000124	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—EGR1—kidney cancer	7.02e-05	0.0054	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTP1—kidney cancer	7e-05	0.00539	CbGpPWpGaD
Sibutramine—Decreased appetite—Doxorubicin—kidney cancer	7e-05	0.000122	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—ACHE—kidney cancer	6.95e-05	0.00535	CbGpPWpGaD
Sibutramine—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.95e-05	0.000121	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—EGR1—kidney cancer	6.9e-05	0.00531	CbGpPWpGaD
Sibutramine—Pain—Doxorubicin—kidney cancer	6.88e-05	0.00012	CcSEcCtD
Sibutramine—Constipation—Doxorubicin—kidney cancer	6.88e-05	0.00012	CcSEcCtD
Sibutramine—Feeling abnormal—Doxorubicin—kidney cancer	6.63e-05	0.000116	CcSEcCtD
Sibutramine—Gastrointestinal pain—Doxorubicin—kidney cancer	6.58e-05	0.000115	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—GSTM1—kidney cancer	6.43e-05	0.00495	CbGpPWpGaD
Sibutramine—Urticaria—Doxorubicin—kidney cancer	6.39e-05	0.000112	CcSEcCtD
Sibutramine—Body temperature increased—Doxorubicin—kidney cancer	6.36e-05	0.000111	CcSEcCtD
Sibutramine—Abdominal pain—Doxorubicin—kidney cancer	6.36e-05	0.000111	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—GSTP1—kidney cancer	6.2e-05	0.00477	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—BCHE—kidney cancer	6.06e-05	0.00466	CbGpPWpGaD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	6.05e-05	0.00466	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HIF1A—kidney cancer	5.98e-05	0.0046	CbGpPWpGaD
Sibutramine—Hypersensitivity—Doxorubicin—kidney cancer	5.93e-05	0.000104	CcSEcCtD
Sibutramine—Asthenia—Doxorubicin—kidney cancer	5.77e-05	0.000101	CcSEcCtD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	5.77e-05	0.00444	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTM1—kidney cancer	5.7e-05	0.00439	CbGpPWpGaD
Sibutramine—Pruritus—Doxorubicin—kidney cancer	5.69e-05	9.94e-05	CcSEcCtD
Sibutramine—Diarrhoea—Doxorubicin—kidney cancer	5.51e-05	9.62e-05	CcSEcCtD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	5.48e-05	0.00421	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—ACHE—kidney cancer	5.33e-05	0.0041	CbGpPWpGaD
Sibutramine—Dizziness—Doxorubicin—kidney cancer	5.32e-05	9.29e-05	CcSEcCtD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	5.29e-05	0.00407	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	5.28e-05	0.00406	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	5.28e-05	0.00406	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	5.28e-05	0.00406	CbGpPWpGaD
Sibutramine—Vomiting—Doxorubicin—kidney cancer	5.12e-05	8.94e-05	CcSEcCtD
Sibutramine—Rash—Doxorubicin—kidney cancer	5.07e-05	8.86e-05	CcSEcCtD
Sibutramine—Dermatitis—Doxorubicin—kidney cancer	5.07e-05	8.85e-05	CcSEcCtD
Sibutramine—Headache—Doxorubicin—kidney cancer	5.04e-05	8.8e-05	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	4.85e-05	0.00373	CbGpPWpGaD
Sibutramine—Nausea—Doxorubicin—kidney cancer	4.78e-05	8.35e-05	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	4.68e-05	0.00361	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ATP7B—kidney cancer	4.67e-05	0.0036	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ANXA2—kidney cancer	4.67e-05	0.0036	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC5A3—kidney cancer	4.67e-05	0.0036	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—BCHE—kidney cancer	4.64e-05	0.00357	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	4.24e-05	0.00326	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	4.17e-05	0.00321	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	4.09e-05	0.00315	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—JUN—kidney cancer	3.61e-05	0.00278	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	3.58e-05	0.00275	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	3.37e-05	0.00259	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	3.32e-05	0.00256	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.15e-05	0.00242	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—BRAF—kidney cancer	3.09e-05	0.00238	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—JUN—kidney cancer	2.94e-05	0.00227	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—PTEN—kidney cancer	2.85e-05	0.00219	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.78e-05	0.00214	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.73e-05	0.0021	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.69e-05	0.00207	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—RAF1—kidney cancer	2.58e-05	0.00199	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.51e-05	0.00193	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.46e-05	0.0019	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.4e-05	0.00185	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.38e-05	0.00183	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—BRAF—kidney cancer	2.37e-05	0.00182	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.25e-05	0.00173	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.12e-05	0.00163	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.04e-05	0.00157	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—RAF1—kidney cancer	1.98e-05	0.00152	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—TP53—kidney cancer	1.94e-05	0.0015	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.88e-05	0.00145	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.77e-05	0.00136	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.67e-05	0.00128	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.64e-05	0.00126	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.53e-05	0.00118	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.51e-05	0.00116	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.45e-05	0.00112	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.43e-05	0.0011	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—MAPK1—kidney cancer	1.36e-05	0.00104	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ACY1—kidney cancer	1.28e-05	0.000982	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.2e-05	0.000924	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PDHB—kidney cancer	1.09e-05	0.000835	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—POMC—kidney cancer	1.08e-05	0.000833	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.06e-05	0.000819	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CCBL1—kidney cancer	1.02e-05	0.000785	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GLIPR1—kidney cancer	8.85e-06	0.000681	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPAT—kidney cancer	8.85e-06	0.000681	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APRT—kidney cancer	8.22e-06	0.000633	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—FH—kidney cancer	8.22e-06	0.000633	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GPC3—kidney cancer	7.73e-06	0.000595	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CA2—kidney cancer	7.52e-06	0.000579	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALAD—kidney cancer	7.33e-06	0.000564	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	7.15e-06	0.000551	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	6.99e-06	0.000538	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PGK1—kidney cancer	6.7e-06	0.000516	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC5A3—kidney cancer	6.7e-06	0.000516	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LDHB—kidney cancer	6.57e-06	0.000506	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CA9—kidney cancer	5.7e-06	0.000439	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CRABP1—kidney cancer	4.85e-06	0.000373	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ITPR2—kidney cancer	4.51e-06	0.000347	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ACHE—kidney cancer	4.11e-06	0.000316	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTT1—kidney cancer	4.11e-06	0.000316	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SCARB1—kidney cancer	3.89e-06	0.000299	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTGS1—kidney cancer	3.85e-06	0.000296	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PSMD7—kidney cancer	3.78e-06	0.000291	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—BCHE—kidney cancer	3.58e-06	0.000276	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.54e-06	0.000272	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.41e-06	0.000263	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTP1—kidney cancer	2.85e-06	0.000219	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ABCB1—kidney cancer	2.7e-06	0.000208	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTM1—kidney cancer	2.62e-06	0.000201	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.48e-06	0.000191	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—POMC—kidney cancer	1.85e-06	0.000142	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.48e-06	0.000114	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTEN—kidney cancer	1.29e-06	9.91e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CA—kidney cancer	9.08e-07	6.99e-05	CbGpPWpGaD
